Microbiology
-
Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication
This article has 7 authors:Reviewed by ScreenIT
-
SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways
This article has 9 authors:Reviewed by ScreenIT
-
SARS-CoV-2 variants reveal features critical for replication in primary human cells
This article has 12 authors:Reviewed by ScreenIT
-
Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2
This article has 19 authors:Reviewed by ScreenIT
-
Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without
This article has 7 authors:Reviewed by ScreenIT
-
Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
This article has 11 authors:Reviewed by ScreenIT
-
Lopinavir-ritonavir is not an effective inhibitor of the main protease activity of SARS-CoV-2 in vitro
This article has 7 authors:Reviewed by ScreenIT
-
Elucidating the Antiviral Mechanism of Different MARCH Factors
This article has 6 authors:Reviewed by ScreenIT
-
Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro
This article has 7 authors:Reviewed by ScreenIT
-
Effect of mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion function
This article has 10 authors:Reviewed by ScreenIT